- Home
- GNLX vs SENS Comparison
GNLX vs SENS Comparison
Compare GNLX & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- SENS
- Stock Information
- Founded
- GNLX 2001
- SENS 1996
- Country
- GNLX United States
- SENS United States
- Employees
- GNLX N/A
- SENS N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- SENS Industrial Machinery/Components
- Sector
- GNLX Health Care
- SENS Industrials
- Exchange
- GNLX Nasdaq
- SENS Nasdaq
- Market Cap
- GNLX 103.6M
- SENS 179.7M
- IPO Year
- GNLX 2023
- SENS N/A
- Fundamental
- Price
- GNLX $2.27
- SENS $0.47
- Analyst Decision
- GNLX Strong Buy
- SENS Strong Buy
- Analyst Count
- GNLX 4
- SENS 1
- Target Price
- GNLX $18.25
- SENS $2.00
- AVG Volume (30 Days)
- GNLX 142.7K
- SENS 12.7M
- Earning Date
- GNLX 11-14-2024
- SENS 11-07-2024
- Dividend Yield
- GNLX N/A
- SENS N/A
- EPS Growth
- GNLX N/A
- SENS N/A
- EPS
- GNLX N/A
- SENS N/A
- Revenue
- GNLX $8,000.00
- SENS $22,205,000.00
- Revenue This Year
- GNLX N/A
- SENS $1.05
- Revenue Next Year
- GNLX N/A
- SENS $61.23
- P/E Ratio
- GNLX N/A
- SENS N/A
- Revenue Growth
- GNLX N/A
- SENS 11.41
- 52 Week Low
- GNLX $1.60
- SENS $0.25
- 52 Week High
- GNLX $16.60
- SENS $0.75
- Technical
- Relative Strength Index (RSI)
- GNLX 38.68
- SENS 68.29
- Support Level
- GNLX $2.13
- SENS $0.40
- Resistance Level
- GNLX $2.80
- SENS $0.46
- Average True Range (ATR)
- GNLX 0.20
- SENS 0.05
- MACD
- GNLX -0.04
- SENS 0.01
- Stochastic Oscillator
- GNLX 14.21
- SENS 71.19
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.